Lack of association between serological evidence of past Coxiella burnetii infection and incident ischaemic heart disease: Nested case-control study

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  McCaughey, Conall ^a   Murray, Liam J ^b   McKenna, James P ^a   Coyle, Peter V ^a   O'Neill, Hugh J ^a   Wyatt, Dorothy E ^a   Woodside, Jayne V ^b   Yarnell, John W G ^b   Ducimetiere, Pierre ^c   Bingham, Annie ^c   Amouyel, Philippe ^d   Montaye, Michele ^d   Arveiler, Dominique ^e   Haas, Bernadette ^e   Ferrieres, Jean ^f   Ruidavets, Jean Bernard ^f  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c HÔPITAL PAUL BROUSSE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e MONICA Project   (France)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; BACTERIUM ANTIBODY;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; COXIELLA BURNETII; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; FRANCE; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NONHUMAN; Q FEVER; RISK FACTOR; SEROPREVALENCE; SMOKING; BLOOD; HEART MUSCLE ISCHEMIA; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RISK; UNITED KINGDOM;

ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; COXIELLA BURNETII; FRANCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORTHERN IRELAND; ODDS RATIO; PROSPECTIVE STUDIES; Q FEVER; RISK FACTORS; SMOKING;

EID: 27244457358     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-61     Document Type: Article

References (13)

1. Ender PT, Phares J, Gerson G, Taylor SE, Regnery R, Challener RC, Dolan MJ: Association of Bartonella species and Coxiella burnetii infection with coronary artery disease. J Infect Dis 2001, 183:831-834.
2. Lovey PY, Morabia A, Bleed D, Peter O, Dupuis G, Petite J: Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study. BMJ 1999, 319:284-286.
3. Wildman M, Ayres JG: Long term vascular complications of Coxiella burnetii infection. Cardiovascular risk factors cannot be ignored. BMJ 2000, 320:58-59.
4. Ducimetiere P, Ruidavets JB, Montaye M, Haas B, Yarnell J: Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Int J Epidemiol 2001, 30:1057-1062.
5. Yarnell JW: The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction. QJM 1998, 91:667-676.
6. Rose GA, Blackburn H, Gillum RR, Priveas RJ: Cardiovascular survey methods 2nd edition. Geneva, World Health Organisation; 1982.
7. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
8. Clauss A: [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 1957, 17:237-246.
9. Pierangeli L, Nuzzolo L, Calabro R, Villanti P: [Myocardial infarct in the presence of serum antibodies against Coxiella burneti]. Boll Soc Ital Cardiol 1967, 12:205-209.
10. Dupuis G, Petite J, Peter O, Vouilloz M: An important outbreak of human Q fever in a Swiss Alpine valley. Int J Epidemiol 1987, 16:282-287.
11. Ayres JG, Wildman M, Groves J, Ment J, Smith EG, Beattie JM: Longterm follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue. QJM 2002, 95:539-546.
12. Ayres JG, Flint N, Smith EG, Tunnicliffe WS, Fletcher TJ, Hammond K, Ward D, Marmion BP: Post-infection fatigue syndrome following Q fever. QJM 1998, 91:105-123.
13. Hatchette TF, Hudson RC, Schlech WF, Campbell NA, Hatchette JE, Ratnam S, Raoult D, Donovan C, Marrie TJ: Goat-associated Q fever: a new disease in Newfoundland. Emerg Infect Dis 2001, 7:413-419.